This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Feb 19;350(8):751-4.

doi: 10.1056/NEJMp038240.

Bone loss after cardiac transplantation

Robert Lindsay¹

Affiliations

PMID: 14973219
DOI: 10.1056/NEJMp038240

Comment

Bone loss after cardiac transplantation

Robert Lindsay. N Engl J Med. 2004.

. 2004 Feb 19;350(8):751-4.

doi: 10.1056/NEJMp038240.

Author

Robert Lindsay¹

Affiliation

¹ Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY, USA.

PMID: 14973219
DOI: 10.1056/NEJMp038240

No abstract available

PubMed Disclaimer

Comment in

Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
Gutteridge DH. Gutteridge DH. N Engl J Med. 2004 May 27;350(22):2306-8; author reply 2306-8. doi: 10.1056/NEJMc040673. N Engl J Med. 2004. PMID: 15163785 No abstract available.

Comment on

Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D. Shane E, et al. N Engl J Med. 2004 Feb 19;350(8):767-76. doi: 10.1056/NEJMoa035617. N Engl J Med. 2004. PMID: 14973216 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information